CSBR - Company ID 0000771856
The table below shows CHAMPIONS ONCOLOGY, INC.'s income statement line items across its last 6 fiscal years, exactly as reported in the company's audited annual filings. All figures are in US dollars; negative values appear in red.
| Line item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
| Revenue | $56.94M | $50.16M | $53.87M | $49.11M | $41.04M | $32.12M |
| Cost of revenue | $28.39M | $29.40M | $29.53M | $23.63M | $21.45M | $17.00M |
| Gross profit | - | - | - | - | - | - |
| R&D | $6.83M | $9.54M | $11.54M | $9.37M | $7.20M | $5.85M |
| SG&A |
CHAMPIONS ONCOLOGY, INC. reported annual revenue of $56.94M for fiscal year 2025. That is up 13.5% from $50.16M in fiscal 2024. Over the 8 fiscal years shown, annual revenue grew from $20.24M (FY 2018) to $56.94M. Figures come from the company's audited annual reports as filed with the SEC.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| $9.34M |
| $11.07M |
| $10.24M |
| $9.12M |
| $6.51M |
| $6.61M |
| Operating income | $4.55M | -$7.36M | -$5.26M | $607.00K | $366.00K | -$1.92M |
| Income tax | -$75.00K | -$32.00K | $68.00K | $35.00K | $75.00K | $130.00K |
| Net income | $4.70M | -$7.28M | -$5.33M | $548.00K | $362.00K | -$2.09M |
| EPS (diluted) | $0.33 | -$0.54 | -$0.39 | $0.04 | $0.02 | -$0.18 |